Mycodern Spolka Akcyjna
MCD | WAR
Overview
Corporate Details
- ISIN(s):
- PLMDNPL00013 (+3 more)
- LEI:
- 25940087YXP4K8ENAO45
- Country:
- Poland
- Address:
- GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK
- Website:
- http://www.mycodern.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Mycodern Spolka Akcyjna specializes in medical innovations, particularly in dermatology and fungal infection treatments. The company combines advanced research with state-of-the-art production to create effective healthcare solutions. Its commitment to addressing unmet medical needs has positioned it as a trusted name in the biotechnology industry. Mycodern aims to improve patient outcomes through innovative and accessible treatments for skin-related conditions.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-04-08 15:20 |
Transaction in Own Shares
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
|
Polish | 2.1 KB | |
| 2024-03-29 20:50 |
Transaction in Own Shares
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
|
Polish | 1.5 KB | |
| 2024-01-23 23:32 |
Regulatory News Service
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
|
Polish | 1.2 KB | |
| 2024-01-23 23:29 |
Prospectus
Dokument Ofertowy - MCD
|
Polish | 388.9 KB | |
| 2024-01-23 23:29 |
Share Issue/Capital Change
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
|
Polish | 1.2 KB | |
| 2024-01-23 17:20 |
Regulatory News Service
Zawarcie umowy o współpracy - Content (PL)
|
Polish | 1.7 KB | |
| 2023-12-31 20:02 |
Declaration of Voting Results & Voting Rights Announcements
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
|
Polish | 183.3 KB | |
| 2023-12-31 20:02 |
Declaration of Voting Results & Voting Rights Announcements
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
|
Polish | 181.8 KB | |
| 2023-12-31 20:02 |
Declaration of Voting Results & Voting Rights Announcements
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
|
Polish | 637 bytes | |
| 2023-12-29 22:27 |
Regulatory News Service
MCD - dokument ofertowy (seria E)
|
Polish | 444.1 KB | |
| 2023-12-29 22:27 |
Regulatory News Service
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
|
Polish | 728 bytes | |
| 2023-11-29 14:02 |
Regulatory News Service
MCD - Dokument ofertowy
|
Polish | 400.2 KB | |
| 2023-11-29 14:02 |
Regulatory News Service
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
|
Polish | 1.5 KB | |
| 2023-10-23 21:09 |
Regulatory News Service
Formularz zapisu - seria E
|
Polish | 168.3 KB | |
| 2023-10-23 21:09 |
Regulatory News Service
Dokument Ofertowy - seria E
|
Polish | 353.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
SenzaGen AB | Sweden | SENZA | |
|
SoftOx Solutions AS | Norway | SOFTX | |
|
Spago Nanomedical AB | Sweden | SPAGO | |
/other/Spermosens_AB_publ-logo.jpg?Expires=1750184849&Signature=pa7eL4ryQ5FZmWWSjCiY3uoAsyyZdQgOtBOPq4DO-1Ma~b9rfIQZUC-me2cFiE-dcyBeR44P7kRNgjl5~mr~W35XTvp6GKZHaZIGROGh13OoDjHNs5HLw3mOI0JR74cuxlIySuQJeJf-CwIbp-wLR~QJejGilxCskpQ7ok7Wlg2tcTG8AHkldeNZndW9OMpYIQkz1z99Pt3JTKgAMpweYxIiGCt9Xt6f2kf1HtVxnLFnFdGbqg85NvUY4leyjbi2kfdIcgDW9HdxFTHfx2qPqqHsxFhYAhCDh6TDpNygboK9NceXT05E4ItgeVv9~jJaiADaMFEP9XfAic3nNZv5Tg__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Spermosens AB (publ) | Sweden | SPERM | |
|
Spexis AG | Switzerland | SPEX | |
|
Sprint Bioscience | Sweden | SPRINT | |
|
Stayble Therapeutics AB | Sweden | STABL | |
|
Stem Cells Spin Spolka Akcyjna | Poland | SCS | |
|
Strategic Partners A/S | Denmark | STRAP | |
|
STRIX GROUP PLC | Isle of Man | KETL |